ACIP gets new chair; Chinese government taps Novavax to supply flu vax in 2015 campaign;

> Dr. Nancy Bennett, director of the Center for Community Health at the University of Rochester Medical Center, has been appointed chair of the Advisory Committee on Immunization practices. Release

> Novavax published data from its RSV F Phase II trial involving women of child-bearing age in the Journal of Infectious Disease. Release

> The Chinese government has chosen Sinovac to be one of its vaccine suppliers for its 2015 flu vaccine campaign. Release

And Finally... Vaccine billionaire Cyrus Poonawalla, Serum Institute of India's chairman and managing director, shelled out $113 million for the former U.S. consulate in Mumbai. Story

Suggested Articles

With its phase 3 trial moving right along, Moderna is expecting efficacy data in November—likely after Pfizer and BioNTech, but before everyone else.

BioNTech expects a quick turnaround once the transaction closes and plans to produce up to 250 million doses of BNT162b2 in the first half of 2021.

Participation in clinical trials among Black people is low, FDA statistics show, even as drugmakers prioritize including them in COVID-19 shot trials.